Predict your next investment

Fareva company logo
Corporation
INDUSTRIALS | Basic Materials
fareva.com

See what CB Insights has to offer

Partners & Customers

6

About Fareva

Fareva is a global sub-contractor in the cosmetics, pharmaceuticals, industrial, and home care fields. It offers research, manufacturing, and packaging solutions.

Fareva Headquarter Location

28 Place de la Gare

Luxembourg City, 1616,

Luxembourg

+33 0475078210

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Fareva Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Fareva Rank

Latest Fareva News

Fareva, ApiJect Sign 10-Year Blow-Fill-Seal Licensing Agreement

Dec 10, 2021

Fareva, ApiJect Sign 10-Year Blow-Fill-Seal Licensing Agreement Fareva, ApiJect Sign 10-Year Blow-Fill-Seal Licensing Agreement Invests $56.5M to fill-finish more than 500 million doses per year of vaccines and other large molecule injectable drugs using ApiJect's technology. 12.10.21 Fareva and ApiJect Systems entered a 10-year licensing agreement to install three Blow-Fill-Seal production lines that when operational will be able to fill-finish more than 500 million doses per year of vaccines and other large molecule injectable drugs using ApiJect's prefilled injector technology. Fareva plans to invest more than $56.5 million for these three manufacturing lines, with support from the Government of France, through the "France Relance" industry initiative and the Investments for the Future Program (PIA). The three manufacturing lines and ApiJect's technology use the Blow-Fill-Seal (BFS) aseptic packaging process. BFS has demonstrated its ability to package certain vaccines and large molecule formulations, and ApiJect is helping to expand BFS's capabilities to additional drug products, including temperature sensitive pharmaceuticals. When cleared by regulators, ApiJect will provide the necessary needle hub and other attachable components to convert finished BFS single-dose containers from these lines into easy-to-assemble, ready-to-use prefilled injectors. By investing in these three BFS lines and installing ApiJect technology, Fareva is helping to increase Europe's high-speed, high-volume Fill and Finish capacity by potentially more than 500 million doses per year. ApiJect CEO and Chair Jay Walker said, "Our mission at ApiJect is to support and execute a strategy of expanded distributed fill-finish capacity in the U.S. and regionally around the world. This is desperately needed in the battle against COVID, particularly as we continue to face emerging variants. Distributed fill-finish capacity will also yield huge dividends when future pandemics and other possible BIO -emergencies threaten our populations. Fareva, along with its support from the French Government, is showing itself to be a vital leader in confronting and defeating the COVID threat. "    The new lines will be situated in Fareva Excelvision in Annonay, France, which has more than 50 years of experience manufacturing BFS containers and exporting products around the world. The BFS machines will be purchased from Rommelag in Germany. Clean rooms for these new lines will be operated in a Biosafety Level 2 (BSL2) environment, allowing them to handle most vaccines. The first Validation batches is expected in June 2022. Related Breaking News 12.10.21 12.10.21 12.09.21 12.09.21 12.09.21 12.09.21 12.08.21 12.08.21 12.08.21 12.08.21 12.08.21 12.08.21 12.08.21 12.08.21 12.08.21

Fareva Acquisitions

1 Acquisition

Fareva acquired 1 company. Their latest acquisition was BCM Manufacturing on October 31, 2017.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

10/31/2017

$99M

Acquired

2

Date

10/31/2017

Investment Stage

Companies

Valuation

$99M

Total Funding

Note

Acquired

Sources

2

Fareva Partners & Customers

6 Partners and customers

Fareva has 6 strategic partners and customers. Fareva recently partnered with ApiJect on December 12, 2021.

Date

Type

Business Partner

Country

News Snippet

Sources

12/9/2021

Licensor

United States

11:31 ET Fareva and ApiJect sign a licensing agreement to create a France-based 500M unit annual capacity for single-dose prefil...

TOURNON-SUR-RHÔNE , France , Dec. 9 , 2021 / PRNewswire / -- Fareva and ApiJect Systems , Corp. today announced a 10-year licensing agreement to install three Blow-Fill-Seal production lines that when operational will be able to fill-finish more than 500 million doses per year of vaccines and other large molecule injectable drugs using ApiJect Systems , Corp. 's innovative prefilled injector technology .

3

12/9/2020

Client

Germany

Subscribe to see more

Subscribe to see more

10

10/8/2018

Vendor

United States

Subscribe to see more

Subscribe to see more

10

10/8/2018

Vendor

United States

Subscribe to see more

Subscribe to see more

10

7/6/2018

Partner

United States

Subscribe to see more

Subscribe to see more

10

Date

12/9/2021

12/9/2020

10/8/2018

10/8/2018

7/6/2018

Type

Licensor

Client

Vendor

Vendor

Partner

Business Partner

Country

United States

Germany

United States

United States

United States

News Snippet

11:31 ET Fareva and ApiJect sign a licensing agreement to create a France-based 500M unit annual capacity for single-dose prefil...

TOURNON-SUR-RHÔNE , France , Dec. 9 , 2021 / PRNewswire / -- Fareva and ApiJect Systems , Corp. today announced a 10-year licensing agreement to install three Blow-Fill-Seal production lines that when operational will be able to fill-finish more than 500 million doses per year of vaccines and other large molecule injectable drugs using ApiJect Systems , Corp. 's innovative prefilled injector technology .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

3

10

10

10

10

Fareva Team

4 Team Members

Fareva has 4 team members, including current Chief Executive Officer, President, Bernard Fraisse.

Name

Work History

Title

Status

Bernard Fraisse

Chief Executive Officer, President

Current

Olivier Allou

Beiersdorf

Senior Vice President

Current

Christophe Petras

Senior Vice President

Current

Géraldine DELEAGE JUVIN

Chief Information Officer

Former

Name

Bernard Fraisse

Olivier Allou

Christophe Petras

Géraldine DELEAGE JUVIN

Work History

Beiersdorf

Title

Chief Executive Officer, President

Senior Vice President

Senior Vice President

Chief Information Officer

Status

Current

Current

Current

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.